Table 1. Demographics, Clinical Characteristics, and Outcomes of Cases and Controls.
| Variable | Cases (n=22) |
Controls (n=44) |
p |
|---|---|---|---|
| Clinical Criteria & non-specific symptoms [n (%)] | |||
| Bilateral Conjuctival injection | 16 (73) | 41 (93) | 0.06b |
| Mucosal changes** | 16 (73) | 37 (84) | 0.46b |
| Polymorphous Rash | 17 (77) | 37 (84) | 0.72b |
| Change of Extremeties*** | 6 (27) | 19 (43) | 0.32b |
| Cervical Lymphadenopathy | 10 (45) | 20 (45) | 0.79b |
| Rinorrhea | 10 (46) | 19 (43) | 0.97b |
| Cough | 8 (36) | 13 (30) | 0.83b |
| Diarrhea | 5 (23) | 5 (11) | 0.35b |
| Emesis | 9 (41) | 3 (7) | 0.02b |
| Sore throat | 0 | 2 (5) | 0.73b |
| Clinical Characteristics & Outcomes | |||
| Days of illness at presentation, median (IQ range) | 5.5 (5-7) | 5 (4-7) | 0.13a |
| Days of fever before IVIG; median (IQ range) | 7 (5-8) | 6 (5-7) | 0.12a |
| Length of stay; median (IQ range) | 4 (3-5) | 3 (3-5) | 0.48a |
| IVIG resistance, [n (%)] | 4 (18) | 8 (18) | 1b |
| Abnornal Echocardiography findings; [n (%)] | 12 (55) | 18 (41) | 0.41b |
| Corornary aneurysms | 2 (9) | 4 (9) | 0.64b |
| Coronary dilation | 9 (42) | 6 (14) | 0.02b |
| Coronary ectasia | 1 (4) | 4 (9) | 0.81b |
| Pericardial Effussion | 0 (0) | 4 (9) | 0.37b |
a
Mann-Whitney test,
b
Z-test for proportions
**
Strawberry tongue or dry, cracked, erythematous lips
***
Change of extermities including: induration of hands and feet with erythematous palms/soles; periungual desquamation